Walmart to roll out Delivery Unlimited grocery service across U.S.

Walmart to roll out Delivery Unlimited grocery service across U.S.

Published: 10 hours ago By Paroma Bhattacharya

Walmart, the retail giant, recently announced that it is rolling out a new Delivery Unlimited grocery service in 1,400 Walmart stores across U.S. Reportedly, the subscription membership will charge an annual fee of USD $98 for subscribers t....

Amazon gears up for Diwali sale, expands next-day delivery service

The firm has increased its overall reach for large appliances to 14,000 pin codes and next-day delivery facilities to over 650 cities. Amazon.in, the Indian division of the e-commerce giant Amazon.com, Inc., has reportedly expanded its del....

Google to open new office in Rochester under Mayo Clinic partnership

This new Google collaboration would involve records such as videos, some reports as well as scans that are stored separately by Mayo Clinic from the Epic Systems’ data.   Mayo Clinic and Google both claim that this move won&r....

4BIO Capital intends to take gene and cell therapies mainstream

The venture capitalist firm has secured an investment of $50 million and is expecting to gather an investment of up to $150 million till 2020. 4BIO Capital, a London-based firm investing in Public Equities in Life Sciences and Venture Capi....

Lung Ambition Alliance reveals plans to double lung cancer survival

New program will be launched to help local initiatives run by patient organizations that contain the capability to further transform patient care.   The Lung Ambition Alliance has built an interactive booth where applicants will un....

SunGen Pharma and Elite Pharmaceuticals file an ANDA with the FDA

This is the second ANDA filed by both the companies, giving Elite Pharmaceutical the exclusive right to retail the drug. Elite Pharmaceuticals, Inc. a pharmaceutical company that creates niche generic products and abuse-deterrent opioids, ....

Ribon Therapeutics doses first patient in RBN-2397 Phase 1 trial

The Phase 1 clinical trial assessing RBN-2397 will be the first clinical evaluation of monoPARP Inhibitor.   RBN-2397 is the company’s PARP7 inhibitor and is capable of potently inhibiting cancer cell proliferation. Ribon T....

Industry Updates